BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10992879)

  • 1. [Role of chlorine transporters and water channels in autosomal dominant polycystic kidneys].
    Devuyst O
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):309-18. PubMed ID: 10992879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of chloride transporters and water channels in autosomal dominant polycystic kidneys].
    Devuyst O
    Bull Mem Acad R Med Belg; 1999; 154(10-12):357-8; discussion 358-61. PubMed ID: 10939167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
    Lebeau C; Hanaoka K; Moore-Hoon ML; Guggino WB; Beauwens R; Devuyst O
    Pflugers Arch; 2002 Sep; 444(6):722-31. PubMed ID: 12355171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion transport and cystogenesis: the paradigm of autosomal dominant polycystic kidney disease.
    Devuyst O; Beauwens R
    Adv Nephrol Necker Hosp; 1998; 28():439-78. PubMed ID: 9890004
    [No Abstract]   [Full Text] [Related]  

  • 5. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.
    Terryn S; Ho A; Beauwens R; Devuyst O
    Biochim Biophys Acta; 2011 Oct; 1812(10):1314-21. PubMed ID: 21255645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.
    Magenheimer BS; St John PL; Isom KS; Abrahamson DR; De Lisle RC; Wallace DP; Maser RL; Grantham JJ; Calvet JP
    J Am Soc Nephrol; 2006 Dec; 17(12):3424-37. PubMed ID: 17108316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
    Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
    Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
    J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to inhibit cyst formation in ADPKD.
    Calvet JP
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting chloride transport in autosomal dominant polycystic kidney disease.
    Jouret F; Devuyst O
    Cell Signal; 2020 Sep; 73():109703. PubMed ID: 32619563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD.
    Thomson RB; Mentone S; Kim R; Earle K; Delpire E; Somlo S; Aronson PS
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F870-80. PubMed ID: 12851251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells.
    Brill SR; Ross KE; Davidow CJ; Ye M; Grantham JJ; Caplan MJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10206-11. PubMed ID: 8816777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease.
    McCarty MF; Barroso-Aranda J; Contreras F
    Med Hypotheses; 2009 Dec; 73(6):1008-10. PubMed ID: 19570618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.
    Davidow CJ; Maser RL; Rome LA; Calvet JP; Grantham JJ
    Kidney Int; 1996 Jul; 50(1):208-18. PubMed ID: 8807590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for CFTR in human autosomal dominant polycystic kidney disease.
    Hanaoka K; Devuyst O; Schwiebert EM; Wilson PD; Guggino WB
    Am J Physiol; 1996 Jan; 270(1 Pt 1):C389-99. PubMed ID: 8772467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis.
    Soleimani M
    JOP; 2001 Jul; 2(4 Suppl):237-42. PubMed ID: 11875265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCO3- transport in relation to mucus secretion from submucosal glands.
    Joo NS; Krouse ME; Wu JV; Saenz Y; Jayaraman S; Verkman AS; Wine JJ
    JOP; 2001 Jul; 2(4 Suppl):280-4. PubMed ID: 11875272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.
    Scott-Ward TS; Li H; Schmidt A; Cai Z; Sheppard DN
    Mol Membr Biol; 2004; 21(1):27-38. PubMed ID: 14668136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.